相关实验视频

Updated: Jan 9, 2026

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

综合多基因数据与机器学习算法的整合揭示了异质分子亚型,并使肝细胞癌的个性化治疗策略成为可能

Zhipeng Jin¹, Kun Fang², Xue Zhang²

¹Department of Hepatopancreatobiliary Surgery, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, China.

|December 3, 2025

概括

这项研究确定了新的分子亚型和肝细胞癌 (HCC) 异质性的风险评分. 这些发现有助于预测HCC患者的预后和指导个性化精确治疗.

科学领域:

在瘤学瘤学.
生物信息学是一种生物信息学.
计算生物学计算生物学

背景情况:

癌症表现出显著的异质性,对预后和治疗构成挑战.
肝细胞癌 (HCC) 的异质性需要更深入的研究,以改善患者的治疗结果.

研究的目的:

为了确定驱动肝细胞癌 (HCC) 异质性的因素.
为了对HCC的预后进行分层,并为个性化治疗策略提供信息.

主要方法:

从使用计算管道的HCC患者集成的多组数据.
应用集群算法和机器学习来定义分子亚型 (MSs) 和风险得分 (MSRRS).
分析了途径丰富,治疗反应和瘤微环境.

主要成果:

在HCC中确定了两个异构的MSS,其中MS2显示出更好的预后.
开发了一种强大的分子亚型相关风险评分 (MSRRS),使用Ridge生存模型,优于其他算法.
MSRRS准确地预测了独立的HCC队列的整体存活率,并提出了指导向治疗,化疗和免疫治疗的潜力.

结论:

新的MS和MSRRS有效地揭示了HCC异质性.
这些发现为预测HCC的预后和指导个性化的精确疗法提供了潜在的潜力.

关键词:

肝细胞癌是肝细胞癌.免疫疗法免疫疗法机器学习是机器学习.分子亚型分子亚型多种多种多种多种多种多种多种多种多种多种.预后预后预后瘤微环境是一个微环境.

更多相关视频

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...